LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT
Clinical trials for LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT explained in plain language.
Never miss a new study
Get alerted when new LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT trials appear
Sign up with your email to follow new studies for LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune therapy combo tested for common blood cancer
Disease control Recruiting nowThis study is testing a new two-drug combination for adults who have not yet received treatment for follicular lymphoma, a type of slow-growing blood cancer. The goal is to see if adding a newer drug (epcoritamab) to a standard one (rituximab) is safe and more effective at contro…
Matched conditions: LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT
Phase: PHASE2 • Sponsor: Reid Merryman, MD • Aim: Disease control
Last updated Mar 10, 2026 12:54 UTC
-
Researchers track daily life impact of cancer care on seniors
Knowledge-focused Recruiting nowThis study aims to understand how standard treatments for slow-growing lymphoma affect the quality of life of patients aged 70 and older. Researchers will observe 150 patients receiving treatments like immunotherapy or radiation, tracking their well-being through questionnaires b…
Matched conditions: LOW GRADE NON-HODGKIN'S LYMPHOMA, ADULT
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC